Yn dangos 1036 i 1050 o 2081 canlyniadau
Joint statement on meeting regulatory standards during periods of global or national shortage of medicines
We are concerned to hear that people with Type 2 diabetes are experiencing problems accessing GLP-1 receptor agonists (GLP-1 RAs).
Our requirements of programmes meeting the revised standards of education and training
Last summer, we asked all pre-registration programmes to plan how they would meet the revised standards of education and training (SETs). From the 2018–19 academic year, we will assess whether your programme has met these standards via our annual monitoring process.